Total net product sales
Breakdown
Segments
Bupivacaine liposome injectable suspensionView metric
EXPARELView metric
iovera°View metric
Net product salesView metric
Royalty revenueView metric
ZILRETTAView metric
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| EXPAREL | $136.85M | $132M | $147.68M | $136.53M | $142.92M | $139.9M | $155.78M | $143.27M |
| ZILRETTA | $30.71M | $28.42M | $33.12M | $23.34M | $31.33M | $28.98M | $32.98M | $26.77M |
| iovera° | $5.67M | $5.66M | $6.45M | $5.12M | $5.59M | $6.47M | $7M | $6.18M |
| Bupivacaine liposome injectable suspension | $3.15M | $1.64M | $0 | $2.6M | $508K | $2.69M | $1.11M | $1.16M |
| Total | $178.02M | $168.57M | $187.25M | $168.92M | $181.1M | $179.52M | $196.87M | $177.38M |